Breast Cancer PBMC

All filters

Format

Format

Format
Sample Attributes

Sample Attributes

Volume
Additive Type
Condition

Condition

Condition

Start typing to see matching condition.

Most stocked

Donor Demographics

Donor Demographics

Gender
Age
Race

Start typing to see matching race.

Country
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request.

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot (SO) #

Start typing to see matching Lot (SO) #.

SKU

Start typing to see matching SKUs.

Donor ID (PID)

Start typing to see matching Donor ID (PID).

5 lots match
5 lots available Save search Notify me
Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request. Sample TypeBag SizeCells / VolumeAdditive TypePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Breast Cancer PBMC 82455 157878 Female 46-60 Caucasian Cryopreserved 1 mL 59 50M EMGALITY – MIGRAINE PROPHYLAXIS 70 MG MONTHLY Breast Cancer United States 2026 01:01:01G/26:01:01G 08:01:01G/35:01:01G 04:01:01G/07:01:01G 03:01:01G/04:02:01G 01:01:01G 03:01:01G/05:01:01G 02:01:01G/03:02:01G 01:03:01G/02:01:02G 01:01:01G/04:01:01G PBMC50M cellsACDBreast CancerBreast CancerNo23.29Non ReactiveNoYesNoYesNOYesStoredIn Stock
$1,195 / vial 59 vials left
Breast Cancer PBMC 82455 157878 Female 46-60 Caucasian Cryopreserved 1 mL 9 10M EMGALITY – MIGRAINE PROPHYLAXIS 70 MG MONTHLY Breast Cancer United States 2026 01:01:01G/26:01:01G 08:01:01G/35:01:01G 04:01:01G/07:01:01G 03:01:01G/04:02:01G 01:01:01G 03:01:01G/05:01:01G 02:01:01G/03:02:01G 01:03:01G/02:01:02G 01:01:01G/04:01:01G PBMC10M cellsACDBreast CancerBreast CancerNo23.29Non ReactiveNoYesNoYesNOYesStoredIn Stock
$1,195 / vial 9 vials left
Breast Cancer PBMC 73503 141760 Female 46-60 Caucasian Cryopreserved 1 mL 67 50M Lialda 4x1.2 g daily Levythyroxine.100 mg daily Norvasc - 5md daily Zepbound- .5 weekly Zofran 4 mg as needed Albuterol inhaler as needed Wellbutrin daily 150mg Famatodine 20 mg daily Ulcerative Colitis, Graves' Disease, Atopic Dermatitis (Eczema), Breast Cancer United States 2026 02:01:01G 07:02:01G/44:02:01G 05:01:01G/07:02:01G 12:01:01:01/15:01:01:01 — 01:02:01:01/05:05:01:03 03:01:01:05/06:02:01:01 01:03:01:03/01:03:01:04 03:01:01:01/04:01:01:01 PBMC50M cellsACDBreast CancerBreast Cancer;Ulcerative Colitis;Graves' Disease;Atopic DermatitisNo21.63Non ReactiveYesYesNoYesNOYesARH+97.084615.0911.0624.38StoredIn Stock
$1,195 / vial 67 vials left
Breast Cancer PBMC 73944 142830 Female 61+ Caucasian Cryopreserved 1 mL 55 50M No medications Breast Cancer United States 2026 A*02:01:01:01/A*32:01:01:01 — — — — — — — — PBMC50M cellsACDBreast CancerBreast CancerNo20.94Non ReactiveYesNoNoYesNOYesStoredIn Stock
$1,195 / vial 55 vials left
Breast Cancer PBMC 73944 142830 Female 61+ Caucasian Cryopreserved 1 mL 8 10M No medications Breast Cancer United States 2026 A*02:01:01:01/A*32:01:01:01 — — — — — — — — PBMC10M cellsACDBreast CancerBreast CancerNo20.94Non ReactiveYesNoNoYesNOYesStoredIn Stock
$1,195 / vial 8 vials left

Adding a lot to your cart does not reserve it. Lots are confirmed when the order is placed.

Vial counts can change between daily syncs; a ✓ shows when a lot's count was last checked, not a hold.

Showing 1–5 of 5 lots* Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request.

About Breast Cancer PBMC

Breast Cancer PBMC are sourced from consented donors with documented breast cancer. These samples support immune-cell research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Breast Cancer research
  • Immune-cell phenotyping
  • Cellular functional assays
  • Single-cell and bulk transcriptomics
  • Drug-response research

Product Features

  • Peripheral blood mononuclear cells
  • Donor condition: Breast Cancer
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Processing specifications

Anticoagulant
Confirmed per lot on request
Isolation
Density-gradient centrifugation (SepMate™); optional RBC lysis
Processing window
Processed within ~24 hours of collection unless otherwise stated
Cryopreservation
Cryopreservation medium with 10% DMSO; controlled-rate freezing (−1 °C/min)
Storage
Vapor-phase liquid nitrogen
Count and viability
Automated dual-fluorescence cell counter; cells per vial listed per lot
Aliquot sizes
5M cells (5 × 10⁶)10M cells (1 × 10⁷)

From Sanguine's processing protocols. View protocols

Donor and clinical data in these lots

Fields recorded on the 5 in-stock lots for this product. Coverage varies by donor; blank fields are not available for that lot.

Donor

Sex
5 of 5 lots
Age
5 of 5 lots
Race
5 of 5 lots
BMI
5 of 5 lots

Clinical history

Primary diagnosis
5 of 5 lots
Current medications
5 of 5 lots
Comorbidities (donor-reported)
1 of 5 lots
Primary diagnosis is EHR-verified. Comorbidities are donor-reported; EHR-verified comorbidity data is available on request.
Allergies
5 of 5 lots
Infectious disease history
5 of 5 lots

Lab results & genotype

CMV serostatus
5 of 5 lots
ABO / Rh blood type
1 of 5 lots
HLA class I typing
5 of 5 lots
HLA class II typing
3 of 5 lots
Flow cytometry immunophenotype
1 of 5 lots

Lifestyle

Tobacco use
5 of 5 lots
Alcohol use
5 of 5 lots
Recreational drug use
5 of 5 lots
Caffeine use
5 of 5 lots

Collection

Collection date
5 of 5 lots
Country of collection
5 of 5 lots

Need a field that isn't listed, such as disease stage or time since diagnosis?

Shipping terms

Ships frozen on dry ice from the US. International orders welcome.

Domestic

Rates
Shipped frozen on dry ice by overnight courier. $411 per order up to $8,000; $935 above $8,000. Leukopaks: $935 per cryopreserved bag, $550 per fresh bag. Fresh whole blood: $216 per 3 healthy donors or per disease-state donor.
Dispatch
In-stock samples ship in 2 business days.
Own courier account
You can ship on your own courier account. You bear all transit risk and must declare the full value of the shipment.

International

Rates
$750 per order, shipped on dry ice by a courier designated by Sanguine unless you ask for an alternative.
Title and risk
Title and risk pass to you when the shipment is handed to the carrier (Incoterms 2020 EXW).
Permits, customs and duties
You are responsible for import permits, customs clearance, duties and taxes, and for complying with the export and import laws that apply to you.
Delays
Sanguine is not responsible for delays caused by carriers, customs, or external events.
Own courier account
You can ship on your own courier account. You bear all transit risk and must declare the full value of the shipment.

More detail on our shipping charges page.

Quality and protocols

  • PBMC Isolation from Whole Blood

    Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.

    Download
  • Immune Cell Isolation

    Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.

    Download
  • Choosing the Right PBMC Configuration

    Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.

    Download
  • Thawing Cryopreserved PBMC

    Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

PBMC

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Breast Cancer PBMC with normal donor samples for comparison

Healthy Donor PBMCs

735 In Stock
Screened normal donors · Cryopreserved · Starting at $205
View Inventory

Need a custom PBMC cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information